Transaction #27044 · Form 4 · 0001683607-26-000002

Royalty Pharma plc · Stock award · Class A Ordinary Shares

Royalty Pharma plc · Transacted December 31, 2025 · Filed January 2, 2026

Original SEC filing ↗

What does this filing report?

An SEC Form 4 filing for Royalty Pharma plc records a stock award involving Class A Ordinary Shares on December 31, 2025. The reported quantity was 967. The filing date is January 2, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Transaction details

Company CIK
0001802768
Security type
Non-derivative
Acquisition type
Stock award · Code A
Quantity acquired
967
Reported price
38.7418 · See footnotes
Reference value
37,463.3206
Currency
Currency not specified
Ownership
Direct
Holdings after transaction
73,132
Ownership description
Not reported
SEC acceptance time
Jan 2, 2026, 4:06 PM EST
10b5-1 indication
Not indicated

Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.

Reporting owners

These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.

Company listings

RPRX · Nasdaq

This transaction is not mapped to a specific company listing.

Filing footnotes & remarks

F1
Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.

This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.